CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 60  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0873
LYS 10.0741
GLU 20.0624
LEU 30.0440
ARG 40.0194
CYS 50.0089
GLN 60.0123
CYS 70.0054
ILE 80.0378
LYS 90.0164
THR 100.0206
TYR 110.0214
SER 120.0312
LYS 130.0439
PRO 140.0126
PHE 150.0042
HIS 160.0228
PRO 170.0105
LYS 180.0163
PHE 190.0152
ILE 200.0109
LYS 210.0119
GLU 220.0072
LEU 230.0080
ARG 240.0033
VAL 250.0065
ILE 260.0245
GLU 270.0286
SER 280.0275
GLY 290.0534
PRO 300.0695
HIS 310.0420
CYS 320.0204
ALA 330.0147
ASN 340.0286
THR 350.0224
GLU 360.0156
ILE 370.0138
ILE 380.0146
VAL 390.0129
LYS 400.0124
LEU 410.0107
SER 420.0117
ASP 430.0262
GLY 440.0107
ARG 450.0191
GLU 460.0187
LEU 470.0174
CYS 480.0126
LEU 490.0122
ASP 500.0203
PRO 510.0274
LYS 520.0873
GLU 530.0411
ASN 540.0338
TRP 550.0207
VAL 560.0222
GLN 570.0257
ARG 580.0142
VAL 590.0025
VAL 600.0086
GLU 610.0130
LYS 620.0091
PHE 630.0038
LEU 640.0055
LYS 650.0133
ARG 660.0068
ALA 670.0076
GLU 680.0238
ASN 690.0217

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.